NPs Basic Information

Name
Penicibrocazine E
Molecular Formula C20H24N2O6S2
IUPAC Name*
(1R,4R,5R,9R,11R,14R,15S,19S)-5,15-dihydroxy-1,11-bis(methylsulfanyl)-3,13-diazapentacyclo[11.7.0.03,11.04,9.014,19]icos-6-ene-2,8,12,18-tetrone
SMILES
CS[C@@]12C[C@H]3[C@@H](N1C(=O)[C@@]4(C[C@@H]5[C@@H](N4C2=O)[C@@H](C=CC5=O)O)SC)[C@H](CCC3=O)O
InChI
InChI=1S/C20H24N2O6S2/c1-29-19-7-9-11(23)3-5-13(25)15(9)21(19)18(28)20(30-2)8-10-12(24)4-6-14(26)16(10)22(20)17(19)27/h3,5,9-10,13-16,25-26H,4,6-8H2,1-2H3/t9-,10+,13+,14-,15+,16+,19+,20+/m0/s1
InChIKey
QOXQVMHGUNMPOZ-BHACCYINSA-N
Synonyms
Penicibrocazine E
CAS NA
PubChem CID 139583686
ChEMBL ID NA
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organic acids and derivat
      • Class: Carboxylic acids and deri
        • Subclass: Amino acids, peptides, an
          • Direct Parent: Alpha amino acids and der

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 452.5 ALogp: -0.9
HBD: 2 HBA: 8
Rotatable Bonds: 2 Lipinski's rule of five: Accepted
Polar Surface Area: 166.0 Aromatic Rings: 5
Heavy Atoms: 30 QED Weighted: 0.611

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.021 MDCK Permeability: 0.00001800
Pgp-inhibitor: 0.45 Pgp-substrate: 0.489
Human Intestinal Absorption (HIA): 0.282 20% Bioavailability (F20%): 0.007
30% Bioavailability (F30%): 0.049

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.001 Plasma Protein Binding (PPB): 59.93%
Volume Distribution (VD): 0.353 Fu: 36.60%

ADMET: Metabolism

CYP1A2-inhibitor: 0.001 CYP1A2-substrate: 0.218
CYP2C19-inhibitor: 0.04 CYP2C19-substrate: 0.882
CYP2C9-inhibitor: 0.372 CYP2C9-substrate: 0.165
CYP2D6-inhibitor: 0 CYP2D6-substrate: 0.049
CYP3A4-inhibitor: 0.138 CYP3A4-substrate: 0.974

ADMET: Excretion

Clearance (CL): 8.547 Half-life (T1/2): 0.937

ADMET: Toxicity

hERG Blockers: 0.001 Human Hepatotoxicity (H-HT): 0.162
Drug-inuced Liver Injury (DILI): 0.98 AMES Toxicity: 0.004
Rat Oral Acute Toxicity: 0.959 Maximum Recommended Daily Dose: 0.612
Skin Sensitization: 0.23 Carcinogencity: 0.297
Eye Corrosion: 0.003 Eye Irritation: 0.006
Respiratory Toxicity: 0.001
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC002661 0.745 D0I5DS 0.220
ENC003671 0.745 D0D1SG 0.214
ENC003673 0.514 D0IL7L 0.214
ENC003573 0.477 D08PIQ 0.211
ENC003809 0.455 D0V9DZ 0.211
ENC003617 0.454 D0D2TN 0.211
ENC000993 0.309 D0CZ1Q 0.211
ENC006009 0.287 D04SFH 0.210
ENC005509 0.287 D0Y7IU 0.209
ENC003035 0.277 D04QNO 0.209
*Note: the compound similarity was calculated by RDKIT.